Paloma Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-64,800
Closed -$6.73M 432
2024
Q3
$6.73M Buy
64,800
+55,300
+582% +$5.64M 0.19% 116
2024
Q2
$922K Buy
+9,500
New +$876K 0.03% 541
2024
Q1
Sell
-22,000
Closed -$1.75M 813
2023
Q4
$1.75M Buy
22,000
+11,100
+102% +$835K 0.06% 298
2023
Q3
$775K Buy
+10,900
New +$815K 0.03% 413
2019
Q3
Sell
-16,100
Closed -$1.15M 1996
2019
Q2
$1.15M Buy
+16,100
New +$1.14M 0.02% 644
2018
Q4
Sell
-80,300
Closed -$5.38M 1332
2018
Q3
$5.38M Buy
+80,300
New +$5.35M 0.1% 170
2018
Q2
Sell
-25,000
Closed -$1.79M 1681
2018
Q1
$1.79M Hold
25,000
0.03% 647
2017
Q4
$1.89M Buy
+25,000
New +$1.83M 0.03% 697

Other funds holding CL

Paloma Partners's CL Position: Q4 2024 in Review

Paloma Partners sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 29,915 shares — an estimated $3.11M sold.

Paloma Partners first reported a position in CL in Q2 2013 and held it in 34 quarters. The position peaked at $24.4M in Q2 2021. 1,933 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • Paloma Partners reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 29,915 Colgate-Palmolive shares in Q4 2024, an estimated $3.11M.
  • Paloma Partners first reported a position in Colgate-Palmolive in Q2 2013 and held it in 34 quarters.
  • Paloma Partners's Colgate-Palmolive position peaked at $24.4M in Q2 2021.
  • 1,933 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.